These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6085395)

  • 21. Depression, psychosis and dementia in Parkinson's disease.
    Baker MG
    Neurology; 1999; 52(7 Suppl 3):S1. PubMed ID: 10227601
    [No Abstract]   [Full Text] [Related]  

  • 22. Behavioral dysfunction in Parkinson's disease.
    Friedman JH
    Clin Neurosci; 1998; 5(2):87-93. PubMed ID: 10785833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reaction time and vigilance in Parkinson's disease. Possible role of altered norepinephrine metabolism.
    Stern Y; Mayeux R; Côté L
    Arch Neurol; 1984 Oct; 41(10):1086-9. PubMed ID: 6206831
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Involuntary movements other than Parkinsonism: biochemical aspects.
    Curzon G
    Proc R Soc Med; 1973 Sep; 66(9):873-6. PubMed ID: 4281484
    [No Abstract]   [Full Text] [Related]  

  • 25. Apathy Profile in Parkinson's and Huntington's Disease: A Comparative Cross-Sectional Study.
    Sousa M; Moreira F; Jesus-Ribeiro J; Marques I; Cunha F; Canário N; Freire A; Januário C
    Eur Neurol; 2018; 79(1-2):13-20. PubMed ID: 29131091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intellectual dysfunction and dementia in Parkinson disease.
    Mayeux R; Stern Y
    Adv Neurol; 1983; 38():211-27. PubMed ID: 6351560
    [No Abstract]   [Full Text] [Related]  

  • 27. Analyzing the subcortical dementia syndrome of Parkinson's disease using the RBANS.
    Beatty WW; Ryder KA; Gontkovsky ST; Scott JG; McSwan KL; Bharucha KJ
    Arch Clin Neuropsychol; 2003 Jul; 18(5):509-20. PubMed ID: 14591446
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Monoamine metabolism and depression in Parkinson patients.
    Puite JK; Schut T; van Praag HM; Lakke JP
    Psychiatr Neurol Neurochir; 1973; 76(1):61-70. PubMed ID: 4699106
    [No Abstract]   [Full Text] [Related]  

  • 29. Altered serotonin metabolism in depressed patients with parkinson's disease.
    Mayeux R; Stern Y; Cote L; Williams JB
    Neurology; 1984 May; 34(5):642-6. PubMed ID: 6200801
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Error processing in normal aging and in basal ganglia disorders.
    Beste C; Willemssen R; Saft C; Falkenstein M
    Neuroscience; 2009 Mar; 159(1):143-9. PubMed ID: 19166908
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alterations in glutathione levels in Parkinson's disease and other neurodegenerative disorders affecting basal ganglia.
    Sian J; Dexter DT; Lees AJ; Daniel S; Agid Y; Javoy-Agid F; Jenner P; Marsden CD
    Ann Neurol; 1994 Sep; 36(3):348-55. PubMed ID: 8080242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Levodopa in Huntingtons chorea.
    Sishta SK; Templer DI
    Can Med Assoc J; 1976 May; 114(9):798-9. PubMed ID: 131644
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Prevalence of mental disorders in persons with Parkinson's disease].
    de Rijk C; Bijl RV
    Ned Tijdschr Geneeskd; 1998 Jan; 142(1):27-31. PubMed ID: 9556986
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The fate of striatal dopaminergic neurons in Parkinson's disease and Huntington's chorea.
    Huot P; Lévesque M; Parent A
    Brain; 2007 Jan; 130(Pt 1):222-32. PubMed ID: 17142832
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clozapine therapy for Parkinson's disease and other movement disorders.
    Pfeiffer C; Wagner ML
    Am J Hosp Pharm; 1994 Dec; 51(24):3047-53. PubMed ID: 7856623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amine precursors in neurologic disorders and the psychoses.
    Klawans H
    Res Publ Assoc Res Nerv Ment Dis; 1975; 54():259-76. PubMed ID: 130667
    [No Abstract]   [Full Text] [Related]  

  • 37. Associative learning in degenerative neostriatal disorders: contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases.
    Sprengelmeyer R; Canavan AG; Lange HW; Hömberg V
    Mov Disord; 1995 Jan; 10(1):51-65. PubMed ID: 7885356
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Electroconvulsive therapy in patients with Huntington's disease and depression].
    van Duijn E; Roos RA; Smarius LJ; van der Mast RC
    Ned Tijdschr Geneeskd; 2005 Sep; 149(39):2141-4. PubMed ID: 16223071
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Mental dysfunction in Parkinson's disease].
    Růzicka E
    Cas Lek Cesk; 1996 Apr; 135(7):199-203. PubMed ID: 8681366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neuropsychiatric comorbidities in Huntington's and Parkinson's Disease: A United States claims database analysis.
    Ishihara L; Oliveri D; Wild EJ
    Ann Clin Transl Neurol; 2021 Jan; 8(1):126-137. PubMed ID: 33217173
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.